Retinoid-induced hypercalcemia in a patient with Kaposi sarcoma associated with acquired immunodeficiency syndrome

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 5, 1998, Pages 513-517

  Aboulafia, David M ^a,b   Bundow, Denise ^a   Weaver, Cheryl ^c   Yokum, Richard C ^d  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Hypercalcemia; Kaposi sarcoma; Retinoids

Indexed keywords

ALITRETINOIN; COTRIMOXAZOLE; INDINAVIR; LAMIVUDINE; NIZATIDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALOPECIA; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL TRIAL; DRY SKIN; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; KAPOSI SARCOMA; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DERMATOLOGIC AGENTS; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; RETINOIDS; SARCOMA, KAPOSI;

EID: 0031724860     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199810000-00020     Document Type: Article

References (46)

1. Warrell RP Jr. Retinoids in cancer. In: Kimball ES, ed. Immunopharmaceuticals. Boca Raton: CRC Press, 1995;101.
2. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990;345:224-9.
3. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997:337;1021-8.
4. Lippman SM, Meyskens FL Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 1987;107:499-502.
5. Berg WJ, Schwartz L, Amsterdam A, Mazumdar M, Nanus DM, Motzer RJ. Clinical studies of 13-cis-retinoic acid (CRA) in patients with metastatic renal cell carcinoma (RCC) [Abstract]. Proceedings of the American Society of Clinical Oncology 1997;16:1162a.
6. Lee FC, Mitsuyasu RT. Chemotherapy of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am 1996; 10:1051-68.
7. Leoung GS, Aboulafia D, Duvic M, et al. Treatment of Kaposi's sarcoma using targrentin™ (LGD 1057), a topical retinoid [Abstract]. International Conference on AIDS 1996;11:27.
8. Duvic M, Friedman-Kien AE, Galpin J, et al. Phase I/II clinical trial supports safety and efficacy of ALRT 1057 topical retinoid gel for Kaposi's sarcoma [Abstract]. International Conference on AIDS 1996;11:27.
9. Warrell RP Jr. Differentiation agents. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997;483-90.
10. Ahmed B, Jaspan JB. Case report: hypercalcemia in a patient with AIDS and pneumocystic carinii pneumonia. Am J Med Sci 1993;306:313-6.
11. Niesvizky R, Siegel DS, Busquets X, et al. Hypercalcemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma. Br J Haematol 1995;89:217-8.
12. Villablanca JG, Khan AA, Avramis VI, Reynolds CP. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid. Am J Pediatr Hematol Oncol 1993;15:410-5.
13. Fisher G, Skillern PG. Hypercalcemia due to hypervitaminosis A. JAMA 1974;227:1413-4.
14. Sakakibara M, Ichikawa M, Amano Y, et al. Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leuk Res 1993;17:441-3.
15. Nagasawa M, Okawa H. All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP. Int J Hematol 1994;59:143-4.
16. Akiyama H, Nakamura N, Nagasaka S, Sakamaki H, Onozawa Y. Hypercalcaemia due to all-trans retinoic acid [Letter]. Lancet 1992;339:308-9.
17. Von Roenn J, von Gunten C, Mullane M, French S, Blough R, Benson AB. All-trans-retinoic acid (TRA) in the treatment of AIDS-related Kaposi's sarcoma (Kaposi's sarcoma: a phase II Illinois Cancer Center Study) [Abstract]. Proceedings of the American Society of Clinical Oncology 1993;12:A6.
18. Kaugars GE, Silverman S Jr, Lovas JG, Thompson JS, Brandt RB, Singh VN. Use of antioxidant supplements in the treatment of human oral leukopkakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:5-14.
19. Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction in keratotic skin lesions during acitretinoin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995;13:1933-8.
20. Vorarud N. Chemoprevention of head and neck cancer. J Med Assoc Thai 1996;79:185-93.
21. Weiss GR, Liu PY, Alberts DS, Gandara DR, Baker LH, Hynes HE. A randomized phase II trial of 13-cis-retinoic acid (CRA) or all-trans retinoic acid (ATRA) plus interferon alpha 2a (IFN) for metastatic or recurrent squamous/adenosquamous carcinoma of the uterine cervix: a Southwest Oncology Group study [Abstract]. Proceedings of the American Society of Clinical Oncology 1997;16:1268a.
22. Etretinate 1996 drug information insert. Physicians desk reference. 52nd ed. Montvale, NJ: Medical Economics Co., 1998;2501-4.
23. Anonymous. Two new retinoids for psoriasis. The Medical Letter 1997:39;105-6.
24. Gianni M, Terao M, Fortino I, et al. Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood 1997;89:1001-12.
25. Guo WX, Gill PS, Antakly T. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation. Cancer Res 1995;55:823-9.
26. Corbeil J, Rapaport E, Richman DD, Looney DJ. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. J Clin Invest 1994;93:1981-6.
27. Ligand Pharmaceuticals. Investigator's Brochure (IB) for Panretin (ALRT 1057) Capsules and Topical Gel. San Diego: Ligand Pharmaceuticals, April 16, 1997.
28. Ziegler JL, Voldberding PA, Itri LM. Failure of isotretinoin in Kaposi's sarcoma [Letter]. Lancet 1984;2:641.
29. Gill PS, Espina BM, Maudgil LT, et al. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma. Leukemia 1994;8(suppl 3):S26-32.
30. Bonhomme L, Fredj G, Maurisson G, Einstein E, Misset JL, Jasmin C. Systemic treatment of AIDS-associated Kaposi's sarcoma (KS) with all-trans retinoic acid (ATRA) [Abstract]. International Conference on AIDS 1993;9:395.
31. Bailey J, Pluda JM, Foli A, et al. Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma. J Clin Oncol 1995;13:1966-74.
32. Muenter MD, Perry HO, Ludwig J. Chronic vitamin A intoxication in adults. hepatic, neurologic and dermatologic complications. Am J Med 1971;50:129-36.
33. Frame B, Jackson CE, Reynolds, WA, Umphrey JE. Hypercalcemia and skeletal effects in chronic hypervitaminosis A. Ann Intern Med 1974;80:44-8.
34. Ragavan VV, Smith JE, Bilezikian JP. Vitamin A toxicity and hypercalcemia. Am J Med Sci 1982;283:161-4.
35. Akiyama H, Nakamura N, Nagasaka S, Sakamaki H, Onozawa Y. Hypercalcemia due to all-trans retinoic acid. Lancet 1992;339:308-9.
36. Sakakibara M, Ichikawa M, Amano Y, et al. Hypercalcemia associated with all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia Res 1993;17:441-3.
37. Cassidy J, Lippman M, La Croix A, Peck G. A phase II trial of 13-cis-retinoic acid in humans. Cancer Res 1982;42:2069-73.
38. Suzumiya J, Asahara F, Katakami H, et al. Hypercalcemia caused by all-trans retinoic acid treatment of acute promyelocytic leukemia: case report. Eur J Haematol 1994;53:126-7.
39. Peter SA. Disorders of serum calcium in acquired immune deficiency syndrome. J Natl Med Assoc 1992;84:626-8.
40. Fallatah S, Halim MA, Ellis ME. Hypercalcemia associated with cytomegalovirus infection in an AIDS patient [Letter]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:101-2.
41. Zaloga GP, Chernow B, Eil C. Hypercalcemia and disseminated cytomegalovirus infection in acquired immunodeficiency syndrome. Ann Int Med 1985;102:331-3.
42. Kantarjian HM, Saad MF, Estey EH, Sellin RV, Samaan NA. Hypercalcemia in disseminated candidiasis. Am J Med 1993;74:721-4.
43. Spindel SJ, Hammill RJ, Georghiou PR, Lacke CE, Greon LK, Mallette LE. Vitamin D-mediated hypercalcemia in fungal infections. Am J Med Sci 1995;310:71-6.
44. Delahunt JW, Romeril KE. Hypercalcemia in a patient with acquired immunodeficiency syndrome and mycobacterium avium intracellulare infection [Letter]. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:871-2.
45. Carbone LD, Land MA, Stentz FB, Palmierl GMA. Elevated cytokine levels in a patient with AIDS and hypercalcemia: effect of therapy with pamidronate [Letter]. Clin Infect Dis 1995;21:699.
46. Poretsky L, Maran A, Zumoff B. Endocrinologic and metabolic manifestations of the acquired immune deficiency syndrome. Mt Sinai J Med 1990;57:236-41.